Investor mix
11 investors on record; lead investors include Boehringer Ingelheim Venture Fund, BioMedPartners, 3B Future Health Fund, Helsinn.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Accelerator & incubator | 1 | 9% |
| Other / undisclosed | 4 | 36% |
Developer of therapeutic vaccine for cancer
11 investors on record; lead investors include Boehringer Ingelheim Venture Fund, BioMedPartners, 3B Future Health Fund, Helsinn.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Accelerator & incubator | 1 | 9% |
| Other / undisclosed | 4 | 36% |